IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution (Q45719667)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 November 2013

Language	Label	Description	Also known as
English	IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution	scientific article published on 20 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution (English)

1 reference

Europe PubMed Central

15 December 2017

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mei-Hsuan Tseng

8

object named as

Mei-Hsuan Tseng

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

13

object named as

Chia-Wen Liu

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

19

object named as

Woei Tsay

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

9

object named as

Chi-Fei Huang

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

7

object named as

Yan-Jun Lai

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ying-Chieh Chiang

10

object named as

Ying-Chieh Chiang

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Chieh-Yu Liu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Chien-Yuan Chen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Fen-Yu Lee

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ming-Chih Liu

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shang-Yi Huang

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shang-Ju Wu

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yao-Chang Chen

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

20 November 2013

1 reference

Europe PubMed Central

15 December 2017

American Journal of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

89

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

137-144

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Myelodysplastic syndromes--coping with ineffective hematopoiesis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Clinical effect of point mutations in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Unraveling the molecular pathophysiology of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Revised international prognostic scoring system for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

A prognostic score for patients with lower risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23596

21 January 2018

Identifiers

10.1002/AJH.23596

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115220%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45719667&oldid=2077785412"